James Lucania - Apr 2, 2025 Form 4 Insider Report for HEALTHEQUITY, INC. (HQY)

Role: EVP & CFO
Signature: /s/ James Lucania
Stock symbol: HQY
Transactions as of: Apr 2, 2025
Transactions value $: -$353,294
Form type: 4
Date filed: 4/4/2025, 05:26 PM
Previous filing: Jan 10, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HQY	Common Stock	Award	$0	+19.7K	+25.85%	$0.00	96K	Apr 2, 2025	Direct	F1
transaction	HQY	Common Stock	Tax liability	-$353K	-4.21K	-4.39%	$83.88	91.8K	Apr 3, 2025	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Shares vest as to 25% of the initial award on April 1, 2026. Shares shall vest as to 6.25% thereafter on the first day of each calendar quarter for the twelve calendar quarters following April 1, 2026.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.8777 to $83.8781 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) of this Form 4.

Content

Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Shares vest as to 25% of the initial award on April 1, 2026. Shares shall vest as to 6.25% thereafter on the first day of each calendar quarter for the twelve calendar quarters following April 1, 2026.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.8777 to $83.8781 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) of this Form 4.